Compare CNTX & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTX | MNY |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Singapore |
| Employees | 15 | 240 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 58.9M |
| IPO Year | 2021 | N/A |
| Metric | CNTX | MNY |
|---|---|---|
| Price | $0.59 | $0.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $6.60 | $4.00 |
| AVG Volume (30 Days) | ★ 2.7M | 57.1K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.66 |
| 52 Week High | $3.62 | $2.40 |
| Indicator | CNTX | MNY |
|---|---|---|
| Relative Strength Index (RSI) | 20.39 | 17.22 |
| Support Level | N/A | N/A |
| Resistance Level | $1.30 | $1.50 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 3.80 | 4.72 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.